Soleno Therapeutics Inc. (SLNO) PT Lowered to $60 at Wolfe, 'We think the stock reaction reflects the focus around new pt starts'
Tweet Send to a Friend
Wolfe Research analyst Kalpit Patel lowered the price target on Soleno Therapeutics Inc. (NASDAQ: SLNO) to $60.00 (from $75.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
